Catalog Products »
GenCRISPR™ Cas9 Genome Editing Products »
GenVAXX™ Pharmaceutical Manufacturing Products
GenVAXX™
The GenVAXX™ product line is a comprehensive portfolio supporting pharmaceutical and biopharmaceutical manufacturing. Applications include mRNA and viral-vector vaccine manufacturing.
The GenVAXX nucleases and kit provide robust, reliable performance with stringent quality controls to support the full pharmaceutical process development.
| Step of the RNA Synthesis Process | GenScript Nuclease Offerings | GenScript Kit Offerings | |
|---|---|---|---|
|
① DNA Template Creation |
Bsal DNA Polymerase dNTP Mix |
GeneBuilder™ Cloning kit | |
|
② In-vitro Transcription |
DNase I
T7 RNA Polymerase RNase Inhibitor Inorganic Pyrophosphatas rNTP Mix Modified UTP: pseudo UTP, 5-OMe-UTP, N1-Me-pseudo UTP |
T7 High Yield RNA
in-vitro Synthesis Kit |
|
|
③ Capping |
2'-O-Methyltransferase (Cap1)
Vaccinia Capping Enzyme (Cap0) SAM GTP |
T7 in-vitro
Transcription with Enzymatic Capping |
T7 in vitro Transcription
Kit with Enzymatic Capping and Tailing |
|
④ Poly (A) Tailing |
Poly A Polymerase | ||
In-vitro Transcription
| Cat. No. | Product Name | Quantity | Price |
|---|---|---|---|
E00071-100 |
Inorganic Pyrophosphatase (yeast) - 100 U |
$250.00 |
|
E00071-10 |
Inorganic Pyrophosphatase (yeast) - 10 U |
$60.00 |
|
E00066-5 |
T7 RNA Polymerase - 5 kU |
$65.00 |
|
E00066-10 |
T7 RNA Polymerase - 10 kU |
$120.00 |
|
E00053-5000 |
DNase I - 5000 U |
$275.00 |
